Koninklijke Philips NV ADR

NYSE PHG

Data sourced from

and

Daily

Download Data

Koninklijke Philips NV ADR Price to Sales Ratio (P/S) on June 03, 2024

Koninklijke Philips NV ADR Price to Sales Ratio (P/S) is NA on June 03, 2024, a NA change year over year. The price to sales ratio compares the market price per share of a company's stock to its sales revenue per share. It is calculated by dividing the market capitalization by the revenue, divided by the number of outstanding shares. This ratio provides insights into the market's valuation of a company's sales revenue. A higher ratio suggests that investors are willing to pay a higher price for each unit of sales revenue, indicating positive market sentiment and expectations for future revenue growth.

Koninklijke Philips NV ADR 52-week high Price to Sales Ratio (P/S) is 1.06 on July 21, 2023, which is NA below the current Price to Sales Ratio (P/S).
Koninklijke Philips NV ADR 52-week low Price to Sales Ratio (P/S) is 0.86 on June 07, 2023, which is NA below the current Price to Sales Ratio (P/S).
Koninklijke Philips NV ADR average Price to Sales Ratio (P/S) for the last 52 weeks is 0.96.

NYSE: PHG

Koninklijke Philips NV ADR

CEO	Dr. Paulus A. Stoffels M.D., Ph.D.
IPO Date	Dec. 30, 1987
Location	Netherlands
Headquarters	Philips Center, Amsterdam, Netherlands, 1096 BC
Employees	69,062
Sector	Healthcare
Industry	Medical devices

Description

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Key trends